The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 304,100 |
| Stock-based compensation | 100,300 |
| Depreciation and amortization | 331,100 |
| Debt restructuring and debt issuance cost amortization and accretion expense | 8,900 |
| Deferred tax provision (benefit) | 43,600 |
| Provision for credit losses | 78,400 |
| Loss on extinguishment of convertible notes | 0 |
| Unrealized loss on interest rate swaps | 0 |
| Other non-cash adjustments | -1,800 |
| Accounts receivable and securitized accounts receivable | 400,600 |
| Prepaid expenses and other current and other long-term assets | -5,200 |
| Accounts payable | -20,100 |
| Accrued expenses and other current and long-term liabilities | -28,500 |
| Income taxes | 30,000 |
| Net cash provided by operating activities | 454,300 |
| Purchases of property, equipment and capitalized software | 140,600 |
| Purchases of equity securities and other investments | 12,400 |
| Purchases of available-for-sale debt securities | 1,725,300 |
| Sales and maturities of available-for-sale debt securities | 1,249,700 |
| Acquisition of intangible assets | 73,100 |
| Acquisitions, net of cash and restricted cash acquired | 0 |
| Other investing activities | -4,700 |
| Net cash used for investing activities | -696,900 |
| Repurchases of common stock | 799,800 |
| Net change in restricted cash payable | 112,300 |
| Net change in deposits | 967,800 |
| Advances from the fhlb | 18,392,500 |
| Repayments to the fhlb | 18,392,500 |
| Net activity on other short-term debt | 21,900 |
| Borrowings on revolving credit facility | 10,084,800 |
| Repayments on revolving credit facility | 10,562,000 |
| Borrowings on term loans | 447,800 |
| Repayments on term loans | 62,300 |
| Proceeds from issuance of senior notes | 550,000 |
| Borrowings on btfp | 0 |
| Repayments on btfp | 0 |
| Repurchase of convertible notes | 0 |
| Payments of deferred and contingent consideration | 76,700 |
| Other financing activities | -40,400 |
| Net cash provided by (used for) financing activities | 418,900 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | 65,100 |
| Net change in cash, cash equivalents and restricted cash | 241,400 |
| Cash and cash equivalents at beginning of period | 1,437,000 |
| Cash and cash equivalents at end of period | 1,678,400 |
WEX Inc. (WEX)
WEX Inc. (WEX)